4 0 7 a r t I C l e S During brain development, a complex pattern of neuronal connections is generated. This pattern is initially established by migration of newly generated neurons toward their final position in the cortical layers of the cerebral cortex. A pool of precursor cells in the ventricular zone and subventricular zone (SVZ) gives rise to most of the neurons and glial cells that form the brain in higher vertebrates [1] [2] [3] . These cells initially migrate toward the pial surface, known as the preplate. The preplate consists of two distinct cell types, the CajalRetzius cells, and a deeper zone of cells called the subplate cells. From this region, neuronal cell bodies migrate back to form the cortical plate where the cortical layers II-VI develop 4 . In rodents, neurogenesis starts early, around embryonic day 9 (E9), and most neurons that form the different layers in the mature cortex reach their positions by migrating radially toward the cortical plate such that those neurons that finally reside in the deeper layers of the cortex migrate first, and later arriving neurons give rise to the more superficial layers, thus generating an inside-out pattern [5] [6] [7] [8] [9] .
a r t I C l e S During brain development, a complex pattern of neuronal connections is generated. This pattern is initially established by migration of newly generated neurons toward their final position in the cortical layers of the cerebral cortex. A pool of precursor cells in the ventricular zone and subventricular zone (SVZ) gives rise to most of the neurons and glial cells that form the brain in higher vertebrates [1] [2] [3] . These cells initially migrate toward the pial surface, known as the preplate. The preplate consists of two distinct cell types, the CajalRetzius cells, and a deeper zone of cells called the subplate cells. From this region, neuronal cell bodies migrate back to form the cortical plate where the cortical layers II-VI develop 4 . In rodents, neurogenesis starts early, around embryonic day 9 (E9), and most neurons that form the different layers in the mature cortex reach their positions by migrating radially toward the cortical plate such that those neurons that finally reside in the deeper layers of the cortex migrate first, and later arriving neurons give rise to the more superficial layers, thus generating an inside-out pattern [5] [6] [7] [8] [9] .
Both intrinsic cues and growth factors influence mitosis, cell cycle exit, migration and synaptic differentiation of neurons in the developing cortex 10 . TrkB and TrkC, the receptors for BDNF and NT-3, are expressed early in developing neurons in the cortical ventricular zone and SVZ and during migration toward their final position in the cortex 11, 12 . Inhibition of TrkB and TrkC via overexpression of dominant-negative constructs results in reduced numbers of proliferating neural precursor cells in the ventricular zone and SVZ, delayed migration and, ultimately, disturbed localization of neurons in the cortical layers 13 . Similar defects in migration of early cortical neurons were observed in mice in which the cytoplasmic tyrosines in the TrkB receptor that mediate docking of Src homology 2 domain-containing-transforming protein C (SHC) and fibroblast growth factor receptor substrate 2 (FRS2) adaptors and phospholipase Cγ (PLCγ) were inactivated, thereby abolishing activation of downstream signaling pathways once the tyrosine kinase activity of the TrkB receptors has been activated. However, it is unclear from these findings whether BDNF or NT-3, the ligands for TrkB and TrkC receptors, activate tyrosine kinases in early neurons to mediate these effects 13 .
We examined the activation of TrkB and TrkC in the developing cortex of embryonic mice. We found that these receptors were activated at early stages of cortical development. Although TrkB and TrkC could be stimulated by BDNF and NT-3, the activation of these receptors was not affected in knockout mice lacking BDNF 14 and/or . Unexpectedly, activation of EGFR by EGF in isolated cortical precursor cells resulted in a robust transactivation of TrkB and also TrkC. This transactivation is responsible for the effects of EGF on the migration of early cortical neurons from the VZ/SVZ toward the cortical layers. Our results suggest that the roles of TrkB and TrkC in newborn neurons of the developing cortex go beyond serving as specific receptors for BDNF and NT-3, and include the mediation and integration of additional signals, particularly those from the EGFR. Thus, TrkB and TrkC transactivation appears to be an essential mechanism for coordination of cortical differentiation when early neuronal cells migrate and integrate into the layers that form the cerebral cortex in higher vertebrates.
RESULTS

Ligand-independent activation of TrkB in cortical neurons
During development, high levels of TrkB are observed in the cerebral cortex long before BDNF expression reaches the high levels found a r t I C l e S which was predominantly recognized by the TrkB antibody in these extracts and immunoprecipitates ( Supplementary Fig. 1 ), indicating that neither BDNF nor NT-3 was necessary for the activation of this receptor at early stages of forebrain development.
EGF activates Trk receptors in cortical precursors
To determine the basis for these observations, we isolated neuronal cells from E12 forebrain 21 . These cell cultures consisted mainly of Pax6-and nestin-positive radial glia-like precursor cells, which formed neurospheres and could be differentiated by plating on laminin (Supplementary Fig. 2 ). These Pax6-and nestin-positive cultures also expressed relatively high levels of TrkB (Fig. 2a,b) . The percentage of MAP2-positive neurons was low during the first 2 d after neurosphere-derived cells were plated on laminin (12.4 ± 3.2%, mean ± s.e.m.; Fig. 2c and Supplementary Fig. 2 ). However, most of these cells expressed nestin (Supplementary Fig. 2 ) and Pax6 (72.5 ± 5.1%, mean ± s.e.m.; Fig. 2c ). Thus, they resembled freshly prepared cortical cells isolated from E11 forebrain (74.4 ± 4.6% Pax6 + and 9.2 ± 3.3% MAP2 + , mean ± s.e.m.; Fig. 2c) . Phosphorylation of Trk receptors, as determined by a phospho-specific antibody to the PLCγ binding site of Trk receptors, was low, and only low levels of activation were observed when these cells were pulsed with BDNF (Fig. 2a,b) . Similarly, freshly prepared cells from E11 embryonic in the adult brain. At E11, TrkB expression was detectable and its expression increased over the course of the next days to higher levels than those observed in early postnatal stages (postnatal day 4, P4; Fig. 1a) . At E13, TrkB was highly expressed in cortical precursor cells of the SVZ and in doublecortin-positive neuronal cells of the early preplate (Fig. 1b) . The SVZ cells, reflecting the neurogenic pool of precursors that give rise to early neurons that migrate from the SVZ toward the preplate at the outer surface of the developing cerebral cortex, expressed activated TrkB, as determined by phosphorylation at the sites of SHC/FRS2 and PLCγ binding (Fig. 1b) . These data are consistent with recent findings that TrkB and TrkC are involved in regulating mitosis 13 of neural precursor cells and migration of early neurons 13, [16] [17] [18] in the developing cerebral cortex. In contrast with TrkB, endogenous BDNF levels are low during embryonic development and expression levels are only elevated after birth 11, 19, 20 . Thus, levels of TrkB activation, as determined using an antibody to the PLCγ binding site of this receptor, did not correlate with the availability of its ligand, BDNF. TrkB phosphorylation was higher at E13 than at P4 (Fig. 1a) .
To investigate whether activation of TrkB occurs independently of neurotrophins at early stages of development, we determined the levels of TrkB phosphorylation in Bdnf −/− and Ntf3 −/− mice 14, 15 . No difference in TrkB activation was observed at E13 in the forebrains of Bdnf −/− mice (pTrk-PLCγ: 94.0 ± 9.4%, n = 2 embryos, t = 0.6341, degrees of freedom (df) = 1, P = 0.6402; pTrk-SHC: 96.6 ± 23.1%, n = 2 embryos, t = 0.1459, df = 1, P = 0.9078; phospho-tyrosine: 97.6 ± 8.6%, n = 2 embryos, t = 0.2852, df = 1, P = 0.8231; mean ± s.e.m., one sample t test) or Ntf3 −/− mice (pTrk-PLCγ: 92.6 ± 9.2%, n = 5 embryos, t = 0.8084, df = 4, P = 0.4642; pTrk-SHC: 96.1 ± 9.7%, n = 3 embryos, t = 0.4045, df = 2, P = 0.7250; phospho-tyrosine: 110.4 ± 4.2%, n = 2 embryos, t = 2.471, df = 1, P = 0.2448; mean ± s.e.m., one sample t test) (Fig. 1c,d) , as determined by TrkB immunoprecipitation and subsequent analysis with antibodies to the phospho-SHC and the phospho-PLCγ sites that recognized all members of the Trk receptor family, and phospho-tyrosine antibodies. In addition, Bdnf −/− ; Ntf3 −/− double knockout mice did not show reduced activation of the TrkB isoform at 130 kDa (pTrk-PLCγ: 80.9 ± 10.6%, n = 2 embryos, t = 1.807, df = 1, P = 0.3218; pTrk-SHC: 76.3 ± 6.7%, n = 2 embryos, t = 3.557, df = 1, P = 0.1745; phospho-tyrosine: 95.4 ± 3.9%, n = 2 embryos, t = 1.187, df = 1, P = 0.4458; mean ± s.e.m., one sample t test; Fig. 1c,d) , npg a r t I C l e S forebrain showed very little response to BDNF or NT-3, in contrast with cells isolated from later stages (E12 and E15), when the percentage of MAP2-positive fully differentiated neurons increased to levels higher than 75% (E12, 57.0 ± 5.1% Pax6 + and 37.7 ± 3.4% MAP2 + ; E15, 7.5 ± 3.0% Pax6 + and 78.9 ± 3.5% MAP2 + ; mean ± s.e.m.; Fig. 2c ).
The relatively low response to BDNF or NT-3 in E11 primary cortical precursor cells and precursor cells derived from neurospheres from E12 forebrain prompted us to investigate the effects of other effectors that were previously identified as transactivators of TrkB [22] [23] [24] . Ligands for the glucocorticoid receptor (Supplementary Fig. 3a ) did not induce increased TrkB activation, in contrast with EGF, which mediated high upregulation of TrkB phosphorylation in 5 min (EGF 5 min: 178.3 ± 12.1%, n = 10 independent experiments, t = 6.460, df = 9, P = 0.0001; EGF 120 min: 164.4 ± 15.5%, n = 8 independent experiments, t = 4.145, df = 7, P = 0.0043; EGF 360 min: 101.3 ± 4.6%, n = 6 independent experiments, t = 0.2886, df = 5, P = 0.7845; mean ± s.e.m., one sample t test; Fig. 2a,c) . This response to EGF was not blocked by BDNFneutralizing antibodies (Supplementary Fig. 3b ) under conditions in which the effects of 10 ng ml −1 BDNF were blocked in primary neuronal cultures 23 . Treatment with EGF resulted in prolonged activation of the MAPK pathway, as shown by Erk1/2 phosphorylation (EGF 5 min: 195.8 ± 21.5%, n = 5 independent experiments, t = 4.467, df = 4, P = 0.0111; EGF 120 min: 196.7 ± 31.3%, n = 4 independent experiments, t = 3.089, df = 3, P = 0.0538; EGF 360 min: 130.0 ± 41.6%, n = 3 independent experiments, t = 0.7222, df = 2, P = 0.5452; mean ± s.e.m., one sample t test; Fig. 2a) . The activation of TrkB could also be seen with antibodies that stained cultured cortical precursors. EGF treatment, in contrast with BDNF or NT-3, resulted in a massive upregulation of pTrk immunoreactivity in cultured nestin-positive cortical precursor cells in 5 min (pTrk-PLCγ: control, 15.6 ± 0.8; EGF, 93.7 ± 4.3; BDNF, 18.0 ± 0.9; NT-3, 21.2 ± 1.2 arbitrary units ± s.e.m.; F = 274.1, R 2 = 0.9904, n = 3; ≥55 cells per condition and experiment; Fig. 2b ). Both the responsiveness to BDNF and to NT-3 in freshly prepared cultures from embryonic forebrain occurred later, at E12 (Fig. 2c) , when the percentage of MAP2-positive neurons increased in cultures, indicating that early cortical precursor cells between E10 and E11 expressing nestin and Pax6 have stronger Trk phosphorylation in response to EGF than to BDNF or NT-3.
Src kinases mediate EGFR transactivation of Trk receptors
Previous data have shown that EGFR expression is high in Pax6-and nestin-positive precursor cells in the subventricular zone, and that expression is asymmetric in dividing precursor cells leaving the ventricular zone and SVZ when they start to migrate as early neurons to the cortical plate [25] [26] [27] . Consistent with these results, we found a high degree of TrkB and EGFR coexpression in neural cells in E13 forebrain (Fig. 2d) .
Transactivation of TrkB by EGF in freshly prepared cortical precursor cells (Fig. 2c) and nestin-positive precursor cells derived from neurospheres ( Supplementary Fig. 2 ) was not only observed with the antibody to the PLCγ site, but also with an antibody that recognizes the SHC/FRS2-binding domains ( npg a r t I C l e S Fig. 3a) . To confirm the identity of the bands recognized by the pTrk antibodies, we transfected HA-tagged TrkB into the cultured cortical precursor cells and determined phosphorylation after immunoprecipitation with an antibody to HA. Only the band migrating at 130 kDa was recognized by the HA antibody in western blots of cell lysates (Fig. 3b) . The activation of TrkB was also detected with the SHC site-specific antibody (Fig. 3a,b) and a phospho-tyrosine antibody (Fig. 3b) . Both the pTrk-SHC and the pTrk-PLCγ antibodies recognized a higher molecular weight band migrating at around 170 kDa. To determine whether this band represented TrkB, we performed shRNA-mediated lentiviral knockdown of TrkB, which led to reduced intensities of the bands for TrkB and pTrk-PLCγ at 130 and 170 kDa ( Supplementary Fig. 4) . A similar reduction was also observed with pTrk-SHC antibodies that were not specific for TrkB, but also recognized activated TrkA and TrkC (Supplementary Fig. 4) . To exclude the possibility that this band represents activated EGFR, we performed pulldown experiments with an antibody to EGFR. No signal was detectable in the eluate using the pTrk-PLCγ antibody, in contrast with an antibody to the EGFR, which revealed a detectable band in the precipitate (Fig. 4a) . The presence of phosphorylated EGFR was controlled by probing with a phospho-tyrosine antibody. Given that shRNA-mediated knockdown of TrkB did not fully abolish the bands representing the phosphorylated forms of TrkB at 170-and 130 kDa, we analyzed neural precursor cells from mice in which the TrkB protein is fully deleted 28 . Both the 130-and 170 kDa bands were still detectable with the pTrk-PLCγ antibodies ( Supplementary  Fig. 5a,b) and, in some experiments (Supplementary Fig. 4a ), the npg a r t I C l e S intensity of the recognized bands was even higher. We then observed that both TrkC immunoreactivity and mRNA levels ( Supplementary  Fig. 5 ) were increased in TrkB knockout neural precursor cells (Supplementary Fig. 5a,c) , indicating that TrkC is also recognized by the pTrk-PLCγ antibodies. Given that the cytosolic PLCγ sites are highly conserved in all members of the Trk family, this was not unexpected. To test this hypothesis, we designed lentiviral shRNA constructs for TrkC knockdown. At 72 h after viral infection, both the 130-and 170-kDa bands recognized by the pTrk-PLCγ antibodies were highly reduced, and, at 96 h after viral infection, they were virtually abolished by the expression of the shRNA construct used for TrkC knockdown (Supplementary Fig. 5a-c) , indicating that the pTrk-PLCγ antibodies recognize TrkC, but not other tyrosine kinase receptors, including EGFR. When the pTrk-SHC antibody that recognizes TrkB and TrkC was used for immunoprecipitation, the pTrk-PLCγ-immunoreactive bands were both precipitated after EGF stimulation (Fig. 4b) . The observation that both the 130-kDa band and the 170-kDa bands reacted with independent TrkB antibodies, but not with EGFR antibodies, provides further evidence that the 170-kDa band includes TrkB and TrkC, which are transactivated after EGF addition.
The activation was abolished by inhibitors of Src kinases, PP1 (at 1 µM) and PP2 (at 100 nM), which have been found to be specific and sufficient to block transactivation of Trk receptors by G proteincoupled receptors in previous studies 29, 30 (Fig. 3b) . The involvement of Src family members was confirmed by using dominant-negative constructs for c-Src (dnSRC) 31 and Fyn (dnFYN) 32 in lentiviral gene transfer experiments (Fig. 3c,d) . The expression of both constructs resulted in a significant reduction of pTrk-PLCγ immunoreactivity (GFP control, 100%; dnSRC, 63.3 ± 8.7%, t = 4.199, df = 2, P = 0.0523; dnFYN, 53.2 ± 12.8%, t = 3.641, df = 2, P = 0.0679; dnSRC and dnFYN, 48.1 ± 7.7%, t = 6.761, df = 2, P = 0.0212; PP1 and PP2, 10.6 ± 4.2%, t = 21.36, df = 2, P = 0.0022; n = 3 independent experiments, one sample t test,) that correlated with the transduction efficacy of the lentiviruses at about 40%, suggesting that c-Src and Fyn are necessary for transactivation of TrkB after EGF treatment. Furthermore, an inhibitor for EGFR signaling 33 completely abolished the activation of TrkB in the cultured cortical precursor cells (Fig. 3b) . Together with the data from the Src inhibitor experiments, these results indicate that c-Src and Fyn are necessary for transactivation of TrkB and TrkC after EGF treatment.
EGFR transactivation elevates cell surface levels of TrkB
To study the cellular basis of why EGF signaling is more potent than BDNF or NT-3 at activating TrkB and TrkC in early E11 cortical precursor cells or in neurosphere-derived cortical precursor cells, we first investigated the subcellular localization of TrkB before and after EGF treatment. TrkB staining in untreated cultured cortical precursor cells was confined to intracellular compartments (Figs. 4 and 5) . This suggests that TrkB, and possibly TrkC, are retained in the endoplasmic reticulum and Golgi compartment in these early cortical precursor cells. To find the cause for this retention, we studied the effect of various deglycosylating enzymes and found that an incubation with peptide N-glycosidase F (PNGase F) shifted the size of the higher molecular weight band for TrkB to 145 kDa (Fig. 4c) . Other glycosidases, including β-1,4-galactosidase and β-N-acetylglucosaminidase, which cleave processed glycosyl side chains typically found in cell surface-exposed proteins 34 , did not shift the molecular weight. To test whether the high degree of N-glycosylation of TrkB found in early cortical precursor cells influences its subcellular distribution, we treated these cells for 12 h with tunicamycin. This treatment, which blocks the first step of N-glycosylation in the endoplasmic reticulum, resulted in enhanced membrane translocation of TrkB (Fig. 4d) in these cells and a shift of the 170-kDa form of TrkB to about 130 kDa (Fig. 4e) . When TrkB was able to translocate to the cell membrane under these conditions, BDNF phosphorylated the 130-kDa form that resulted from reduced glycosylation (Fig. 4e) , indicating that this band reflects npg a r t I C l e S TrkB. A high degree of N-glycosylation, as found in the 170-kDa form of TrkB in E11 primary cortical precursors or neurosphere-derived precursors, has also been found to be involved in sorting of other proteins, such as occludin, to the apical pole of the cell membrane 35 , and increased N-glycosylation of the beta1 subunit of the Na-K-ATPase results in an increased fraction of this protein being distributed to the apical membrane of polarized epithelial cells 36 . Thus, we investigated whether activation of N-hyperglycosylated TrkB via EGFR signaling affects the trafficking of TrkB to the cell membrane. Within 30 s of EGF treatment, TrkB and pTrk immunoreactivity became detectable at the cell surface (Fig. 5a) . To confirm this finding, we performed stimulated emission depletion (STED) microscopy (Fig. 5b) . In untreated cortical precursor cells, STED microscopy only revealed small vesicle-like structures. Following EGF treatment, signals for TrkB and pTrk rapidly moved from intracellular compartments to the cell surface (Fig. 5b) . In addition, avidin pulldown experiments were performed with cells in which cell surface proteins were biotinylated. Again, EGF treatment led to a rapid increase of cell surface-exposed TrkB (178.3 ± 20.4%, t = 6.657, df = 2, P = 0.0218, n = 3 independent experiments, one sample t test; Fig. 5c ), which was blocked by the EGFR inhibitor PD153035 (120.5 ± 19.2%, t = 1.854, df = 2, P = 0.2049, n = 3 independent experiments, one sample t test; Fig. 5c ).
This effect was physiologically relevant, as the translocation was not observed in cortical precursor cells isolated from Egfr −/− mice 37 ( Supplementary Fig. 6a ). When cells were fixed immediately, 2 s after EGF exposure, activation of intracellular TrkB was observed using the pTrk-PLCγ antibody (Supplementary Fig. 6b ). At 10 s after EGF exposure, TrkB translocation to the cell membrane was observed (Supplementary Fig. 6b ), indicating that transactivation of TrkB in intracellular compartments occurs prior to translocation to the cell surface. Similarly, confocal analysis of brain sections from E13 embryos revealed that most cells in the ventricular zone and SVZ expressed TrkB at intracellular sites resembling vesicular and intracellular locations, whereas cells that had already reached the cortical plate exhibited TrkB as a relatively continuous staining on the cell surface (Fig. 5d) . Taken together, these data indicate that TrkB activation in developing cortical neurons leads to translocation of this receptor from an intracellular endoplasmic reticulum-like compartment to the cell surface and that EGFR signaling is more important than endogenous BDNF or NT-3 for TrkB and TrkC activation in the early neurons that start to migrate out of the ventricular zone and SVZ.
Migration of cortical neurons is disturbed in Egfr −/− mice
To confirm this hypothesis, we investigated in vivo TrkB/TrkC phosphorylation in the forebrain of E13 Egfr −/− mouse embryos (Fig. 6a) . Quantitative analysis of densitometric immunoblot scans revealed that pTrk levels were significantly reduced in Egfr −/− mouse brain (pTrk-PLCγ, 89.1 ± 5.2% reduction, t = 16.99, df = 2, P = 0.0034; pTrk-SHC, 96.3 ± 1.8% reduction, t = 53.62, df = 2, P = 0.0003; phosphotyrosine, 96.2 ± 1.9% reduction, t = 49.64, df = 2, P = 0.0004; mean ± s.e.m., n = 3 embryos, one sample t test), whereas TrkB protein levels were not altered (Fig. 6b) . Taken together with the observation that lack of endogenous BDNF, NT-3 or both factors did not alter TrkB phosphorylation at this developmental stage (Fig. 1c,d ), these data indicate that transactivation of TrkB via EGFR signaling is the major activator of TrkB in the developing cortex at this stage.
Recent studies have provided evidence that TrkB and TrkC activation influence migration of early neurons from the ventricular zone and SVZ to the developing cortical plate 13, 16 . In Egfr −/− mice, the layer of neurons in the cortical plate corresponding to layers V and VI of the postnatal brain, which comprises large, pyramidal celllike neurons, was thinner at E16 (Fig. 6c) , and the number of TrkBpositive cells in this layer was significantly reduced (Egfr +/+ , 51.3 ± 4.5%; Egfr −/− , 45.5 ± 3.0%; t = 4.570, df = 34, P < 0.0001, mean ± s.e.m., unpaired t test, counts from six sections from each of three embryos per genotype). Furthermore, the number of TrkB-positive neurons in layer I was increased (Egfr +/+ , 47.9 ± 1.0%; Egfr −/− , 53.2 ± 0.7%; t = 4.233, df = 34, P < 0.0002, mean ± s.e.m., unpaired t test, counts from six sections from each of three embryos per genotype), as was the number of TrkB-positive cells in the ventricular zone and SVZ and the intermediate zone (Egfr +/+ , 0.4 ± 0.1%; Egfr −/− , 0.8 ± 0.1%; t = 4.465, df = 34, P < 0.0001, mean ± s.e.m., unpaired t test, counts from six sections from each of three embryos per genotype), where migrating neurons are expected. Co-staining of TrkB with MAP2 (Fig. 6d) . Similar findings were made after BrdU injection at E13 3 d later in E16 wild-type and Egfr −/− mice (Supplementary Fig. 7) . The number of BrdU cells that had reached layer V/IV at E16 was significantly (P < 0.005) reduced in Egfr −/− brain and was correspondingly increased (P < 0.005) in the cortical plate and marginal zones ( Supplementary  Fig. 7b) . We found no differences in the total numbers of BrdUpositive cells in Egfr −/− and Egfr +/+ mice (Supplementary Fig. 7c ). This is consistent with the observations made with mice in which the SHC/FRS2 and PLCγ sites of TrkB were inactivated 16 . In these mutant mice, migration of early neurons from the ventricular zone and SVZ to the cortical plate is delayed. To investigate whether TrkB transactivation by EGF stimulates migration of early neurons, we plated these cells on laminin-coated cover slips with stripes of EGF or bovine serum albumin (BSA), adopting a technical setup that was used previously to study axon path finding and neural migration 38, 39 . At 6 h after plating, early cortical neurons were equally distributed on BSA and EGF. At 20 h, most of the cells were found on stripes coated with EGF (layer I: EGF, 66.6 ± 2.3%; BSA, 33.4 ± 2.3%; P < 0.001; layer II: EGF, 59.8 ± 1.7%; BSA, 40.1 ± 1.7%; P < 0.001, F = 13.29, R 2 = 0.2598, mean ± s.e.m., one-way ANOVA; Fig. 6e) . No enhanced cell death of cortical precursor cells was observed in regions coated with BSA (data not shown). Cultures where all stripes were coated with BSA or EGF were also analyzed. In such cultures, the distribution of cells stayed the same, no migration was observed (layer III: BSA, 49.2 ± 1.9%; BSA, 50.8 ± 1.9%; P > 0.05; layer IV: EGF, 49.1 ± 1.8%; EGF, 50.8 ± 1.8%; P > 0.05, F = 13.29, R 2 = 0.2598, mean ± s.e.m., one-way ANOVA). Cells stained with antibodies to pTrk-PLCγ showed an asymmetrical staining with an accumulation of activated TrkB at the migration front toward the source of EGF (Fig. 6f and  Supplementary Fig. 8 ). When BDNF stripes were used, early cortical neurons migrated only with low efficacy toward BDNF. In contrast, when EGF was added to the medium, the percentage of cells that migrated toward the BDNF coated stripes significantly increased (without EGF, 55.6 ± 2.3%; with EGF, 68.5 ± 2.1%; P < 0.001, F = 49.20, R 2 = 0.5027, mean ± s.e.m., one-way ANOVA), whereas the proportion of cells on non-BDNF stripes decreased (without EGF, npg a r t I C l e S 44.5 ± 2.3%; with EGF, 31.6 ± 2.1%; P < 0.001, F = 49.20, R 2 = 0.5027, mean ± s.e.m., one-way ANOVA), indicating that EGF enhances the capacity of early cortical neurons to migrate toward BDNF coated substrates (Fig. 6g) .
We did not observe alterations in the mitosis of early TrkB-positive cells in the ventricular zone and SVZ (Supplementary Fig. 7) in Egfr −/− embryonic forebrain, as was observed after injection of constructs encoding dominant-negative forms of TrkB or shRNA for suppression of TrkB 13 into ventricular zone and SVZ precursor cells. However, EGFR was only expressed in cells that migrated out of the SVZ, and a small population of TrkB-positive cells existed in the ventricular zone and SVZ that were strongly stained for TrkB, but not for EGFR (Fig. 2d) , suggesting that mechanisms other than transactivation by EGFR signaling could lead to a mitotic effect via TrkB in this population of EGFRnegative cortical precursor cells. We also did not observe increased apoptosis of TrkB-positive cells at E13 (Supplementary Fig. 9 ) in Egfr −/− mouse embryos, indicating that TrkB activation was not necessary for the survival of early cortical neurons during migration and the early stages at which the different cortical layers form.
DISCUSSION
Extracellular factors are important for neural differentiation. Some of these, such as sonic hedgehog and FGF2, act as morphogens: they are distributed in a gradient and evoke different cellular responses, depending on concentration. Neurotrophins and ligands for the EGFR are involved in guiding migration of newly generated neurons in the developing cortex 25 , and there is evidence for chemotactic responses of axonal growth cones to locally applied BDNF that are mediated via the TrkB receptor [40] [41] [42] . Whether these guidance mechanisms also act on migrating early neurons in the cortex, and whether BDNF is responsible for guiding neurons from the ventricular zone and SVZ to the cortical plate, is less established. We found that TrkB activation was not reduced in BDNF-or NT-3-deficient brain, indicating that the activation of TrkB receptors in early neuronal cells that migrate from the ventricular zone and SVZ toward the cortical plate is ligand independent. In contrast, TrkB activation was reduced in the developing forebrain of Egfr −/− mice in which the migration of neuronal cells from the ventricular zone and SVZ to the cortical plate is disturbed, and suppression or inhibition of c-Src or Fyn, which are known to mediate transactivation of TrkB 29, 30, 43 at intracellular compartments, abolished this transactivation.
Transactivation led to asymmetric recruitment of TrkB to the cell membrane and accumulation of the receptor toward the migrating front of these cells. In the developing forebrain, EGFR expression peaks around E13, the time when neurogenesis is at its maximum. Both in the ventricular zone and the SVZ in mouse embryos, EGFR has been found to be asymmetrically distributed in a subpopulation of about 20% of the dividing cortical precursor cells 27 , indicating that EGFR could be involved in controlling the rate of mitosis and migration in developmental corticogenesis. Together with our data, these observations suggest that the asymmetric location of the EGFR in early migrating neurons that exit the ventricular zone and SVZ determines the asymmetric translocation of TrkB and TrkC into the cell membrane of these early migrating neuronal cells. Indeed, as we found, and as shown previously 44 , defective migration and disturbed formation of cortical layers is a predominant phenotype in EGFR-deficient mice. Similar observations have been made in mice in which TrkB activity was repressed by overexpression of dominant-negative constructs 13 and in mice in which the binding sites for molecules leading to downstream responses after receptor activation are inactivated 16 .
It is not clear whether EGFR and TrkB/TrkC also act together in stimulating mitosis of dividing neural precursor cells in the ventricular zone and SVZ 13, 45 . Experiments in which dominant-negative TrkB or TrkC constructs are overexpressed in these cells have shown that apoptosis is enhanced and mitosis is reduced in neural precursor cells of the ventricular zone and SVZ 13 . Endogenous TrkB is mainly located at intracellular compartments in these cells, both in vivo and in vitro in freshly isolated forebrain neural precursor cells and neurospherederived cells. We did not observe enhanced cell death in the brain of EGFR-deficient developing forebrain. On the other side, robust activation of TrkB was observed in TrkB-positive cells in the ventricular zone and SVZ between E11 and E13, and the levels of TrkB activation were not reduced in BDNF-or NT-3-deficient mouse brain at these developmental stages, indicating that EGFR activation might not be the only mechanism that leads to transactivation of TrkB and TrkC in these early neurons.
In the adult nervous system, activation of EGFR, either by EGF or TGFα 46 , induces mitosis of transit-amplifying type C neural precursor cells in the ventricular zone and SVZ. Moreover, EGF signaling leads to the arrest of neuroblast production and rapid migration of SVZ cells to various positions of the cerebral cortex. Most ligands for the EGFR are bound to membranes and to the extracellular matrix in the developing cortex, and this could lead to asymmetric membrane translocation of TrkB at the migrating front of cortical precursor cells. This explanation is also consistent with the observation that EGFR and TrkB activation cooperate in ovarian cancer cells and stimulate migration of these tumor cells 47 . The translocation of TrkB to the cell surface toward the source of EGF therefore reflects an important step in the differentiation of cortical neurons that occurs during migration toward the cortical plate. Cortical neurons could become responsive to neurotrophins once they reach their final position in the developing cortex and when synaptogenesis starts. Elevated neural activity, as shown previously by treatment of CNS neurons with cAMP or depolarization, could then contribute to the elevation of TrkB cell surface expression and the development of responsiveness to BDNF 48 . This interpretation is supported by our finding that responsiveness to BDNF developed later than TrkB transactivation via EGFR in primary cultures of forebrain neurons, in parallel with the occurrence of MAP2-positive neurons in such cultures (Fig. 2c) .
The paradox of high levels of TrkB activation at early stages, when nestin-and Pax6-positive precursor cells are predominant, and the relative absence of BDNF can be explained by transactivation by other growth factor signals. As BDNF expression is only elevated after birth, when most synapses in the developing cortex are formed, these findings indicate that the TrkB receptor could act as an integrative coordinator of distinct signaling pathways that modulate neural differentiation. Recent findings from mouse models in which TrkB is specifically deleted in hippocampal precursor cells in the adult support this model. These mice have defects in neural migration into the granule cell layer 49 and defects in dendritic development 50 , and they lack responsiveness to antidepressant therapies and have corresponding behavioral abnormalities. Whether this is a result of the shutdown of responses to BDNF or of additional transactivating effects from EGFR and other receptors will be an interesting topic for future studies.
METhODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper. npg confocal microscopy. Digital micrographs were acquired with Leica Confocal Software using the Leica SP2 System. Linear contrast and brightness enhancement was similarly applied within corresponding picture groups. Pictures were arranged and labeled with Adobe Photoshop 7.0.
Statistical analysis. Sample size was chosen according to standard practice in the field, taking into account available numbers of cells per in vitro experiment or mice from same litters, to allow matched controls in which different genotypes or groups were compared under the same conditions. Densitometric intensities in western blots were normalized to loading controls or total protein levels in case of phospho-specific signals. Values from control conditions in each independent experiment were set as 100%. One-sample t test was used to compare the means to this reference value. The intensity of pTrk and phospho-Erk1/2 immunofluorescence signals was measured as arbitrary units per area based on quantum levels per pixel and subjected to statistical analysis, as described previously 54 . Values from at least three independent experiments were pooled, and results were expressed as the mean ± s.e.m. and applied for statistical analysis using GraphPad Prism software. Cells were counted in six sections of a series of coronal 25-µm sections, covering the embryonic telencephalon from rostral to caudal. Forebrains from three mice were used for quantitative analysis of each genotype. 
